Black Diamond Therapeutics, Inc.

UBS Group AG BDTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

257,633

Value ($000)

626

Weight

0.0%

2020 Q1 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	626	0.0%	257,633	12/31/2025
2025 Q3	11/13/2025	2,382	0.0%	628,416	9/30/2025
2025 Q2	8/14/2025	778	0.0%	313,700	6/30/2025
2025 Q1	5/13/2025	198	0.0%	127,794	3/31/2025
2024 Q4	2/14/2025	107	0.0%	49,893	12/31/2024
2024 Q3	11/14/2024	167	0.0%	38,457	9/30/2024
2024 Q2	8/14/2024	124	0.0%	26,534	6/30/2024
2024 Q1	5/13/2024	22	0.0%	4,271	3/31/2024
2023 Q4	2/9/2024	11	0.0%	3,987	12/31/2023
2023 Q3	11/9/2023	1	0.0%	246	9/30/2023
2023 Q2	8/11/2023	43	0.0%	8,519	6/30/2023
2022 Q4	2/8/2023	6	0.0%	3,433	12/31/2022
2022 Q3	11/10/2022	9	0.0%	5,375	9/30/2022
2022 Q2	8/10/2022	44	0.0%	17,599	6/30/2022
2022 Q1	5/16/2022	58	0.0%	20,820	3/31/2022
2021 Q4	2/14/2022	157	0.0%	29,554	12/31/2021
2021 Q3	11/15/2021	143	0.0%	16,821	9/30/2021
2021 Q2	8/13/2021	139	0.0%	11,367	6/30/2021
2021 Q1	5/12/2021	1,048	0.0%	43,189	3/31/2021
2020 Q3	11/12/2020	6	0.0%	197	9/30/2020
2020 Q2	7/31/2020	196	0.0%	4,654	6/30/2020
2020 Q1	5/1/2020	180	0.0%	7,231	3/31/2020